Delivery Order SPE2DB20D1100-SPE2DB24FC2T4
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office division for the provision of IMBRUVICA 420 MG TABLET 28S, a prescription medication. The contract has a ceiling value of $7,322.67 and an ultimate completion date of May 7, 2024. This is not a set-aside contract. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the federal government, holds a larger Indefinite Delivery...
- Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded a $7,322.67 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide IMBRUVICA 420 MG TABLET 28S. This order is a part of Amerisourcebergen's larger indefinite delivery contract (IDC) with DLA to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The IDC, which does not have a set-aside designation,...
- This is a $8,116.87 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMBRUVICA 140 MG CAPSULE 90S, a pharmaceutical product, with a performance period ending on June 12, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order valued at $7,322.67 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The order is for the supply of 420 mg Imbruvica tablets, a prescription medication, with a completion date of July 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025,...
- This is a $7,322.67 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Amerisourcebergen Drug Corporation's Corporate Office Division. The order is for 4,564,522,930 units of the pharmaceutical product IMBRUVICA 420 MG Tablet 28S. The contract has a completion date of May 29, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
- The U.S. Defense Logistics Agency (DLA) awarded a $7,845.72 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for 140 mg Imbruvica capsules. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities in support of military treatment programs and facilities worldwide....
- This is a $8,116.87 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency. The order is for IMBRUVICA 140 MG CAPSULE 90S, a pharmaceutical product. The contract has a completion date of June 25, 2025 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, which provides comprehensive global...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,575.75 firm fixed-price delivery order is for IMBRUVICA 280 MG TABLET 28S, a pharmaceutical product. The contract has an ultimate completion date of March 27, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award, valued at $15,691.44, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is a firm fixed price delivery order for the pharmaceutical product IMBRUVICA 140 MG CAPSULE 90S, with a performance period through April 8, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA, with a potential value of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,116.87 fixed-price delivery order is for the supply of IMBRUVICA 140 mg capsules, a specialty medication used for various medical treatments. The contract has an ultimate completion date of January 7, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FC2T4Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $7,845.72 to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. This contract is for the supply of IMBRUVICA 140 MG CAPSULE 90S, a prescription medication. The contract has an ultimate completion date of July 8, 2024 and was awarded on June 13, 2024. This order is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the U.S. Department of Defense worldwide. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.8k | 6/13/24 |